A carregar...
Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture
The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...
Na minha lista:
| Publicado no: | J Bone Miner Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/ https://ncbi.nlm.nih.gov/pubmed/26969902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...